About Us

1995

The Day-Light 10,000 F/X is Launched

Day-Light launches the 10,000 F/X, a smaller, lighter, and more portable version of the 10,000. This lamp featured an adjustable arm and clamp that latched onto the side of the surface it was attached to.

1996

Day-Light is Used to Study the Effect of Light Therapy on Non-24-Hour Sleep-Wake Disorder

This study explored the effectiveness of light therapy for a patient with Non-24-Hour Sleep-Wake Disorder (N24SWD), a rare condition where the body's internal clock runs on a different schedule than the 24-hour day-night cycle. Using a Day-Light light therapy lamp, the participant initially experienced improved sleep-wake synchronization. However, the positive effects were short-lived, suggesting that longer light therapy durations might be necessary for individuals with a significant circadian rhythm difference.

While light therapy wasn't a complete solution in this case, it offered temporary relief from daytime sleepiness and improved alertness, highlighting its potential as a valuable tool for managing N24SWD symptoms.

1999

Day-Light Technologies Becomes UpLift Technologies

As his passion for healthcare evolved, Michael Speeraw would introduce a series of Uplift seats and commodes. These devices were designed to aid in sitting and standing for those with balance and strength issues. With these new product expansions, Day-Light would change its name to UpLift Technologies.

2000

CAN-SAD Study Shows Promising Results Using the Day-Light 10,000

A clinical study conducted in Canada sought to evaluate the efficacy of light therapy using the Day-Light 10,000 lightbox as compared to an antidepressant in the treatment of seasonal affective disorder (SAD).

Through a double-blind, randomized trial, it was discovered that both treatments yielded similar results in alleviating symptoms and achieving remission.

Light therapy demonstrated a swifter response onset and was associated with fewer adverse effects. Ultimately, the study emphasized that the selection between these two treatment options should be based on individual patient preferences and pertinent clinical considerations.

2000

The Day-Light Classic is Launched

The Day-Light Classic was a revolutionary product born out of our relentless pursuit of innovation. This exceptional device featured three CFL bulbs and a generously sized face, setting it apart as an instant success. Its meticulously crafted design, backed by clinical expertise and patented BrightZone technology, ensured that users could bask in the recommended 10,000 LUX of light from a comfortable sitting distance.

This lamp was featured in an educational video by Sunybrook Hospital out of Canada.

2004

Day-Light Partners with Libraries to Make Light Therapy Accessible

In an effort to ensure that light therapy is easily accessible to everyone, we initiated partnerships with libraries across Canada and the USA. Through this program, library members have the opportunity to visit participating libraries and experience light therapy using our lamps. Additionally, they can even borrow the lamps to use at home. This initiative is our way of not only making light therapy more accessible but also introducing the treatment to individuals and allowing them to try it out to see if it has a positive impact.

Today, our lamps can be found in numerous libraries, including London, Winnipeg, Ohio, Dartmouth, and more.

2007

The Day-Light Sky is Introduced

As the need for bright light therapy increased, we introduced the Day-Light Sky. This contemporary therapy lamp featured a smaller head that delivered the clinical-grade effectiveness of the Day-Light Classic. The Sky was born out of a desire to create a clinical-grade lamp that was more stylish and took up less room.

2012

Carex Health Brands Acquires Uplift Technologies and the Day-Light Brand

As Uplift Technologies grew, it garnered the attention of leading home medical equipment provider Carex Health Brands. Carex would acquire Uplift, and Day-Light would join its other product categories, including pill organizers, hot/cold therapies, and mobility aids.

"The Carex brand has long been admired in the marketplace for many of the same values as Uplift, including quality, value and integrity. I am pleased to hand over the reins to a company which shares my passion for improving the wellbeing of others." - Micheal Speeraw in the press release.

2014

The Day-Light Classic Plus is Born

As awareness of winter blues becomes more widespread, there is a greater need for solutions to address it. This growing demand, along with our commitment to constant innovation, inspired the creation of the Day-Light Classic Plus.
Building upon the clinical-grade effectiveness of the Day-Light Classic, we enhanced it with a new base, an easily adjustable head, and an improved user interface. The updated design maintained the same level of effectiveness while making it much simpler to position the lamp on desks and tables.

2014

Carex Health Brands and Roscoe Medical Merge to Become Compass Health Brands

Carex and Roscoe join forces to create Compass Health Brands, leveraging over 60 years of experience in the home healthcare industry. This strategic merger aimed to capitalize on each company's unique strengths, facilitate more efficient product development, broaden the range of available products, and ultimately deliver enhanced value to customers.

2015

Study Finds the Day-Light Classic Valuable in Addressing Seasonal Mood Disorders by Influencing Brain Chemistry

In a clinical study, researchers investigated the impact of light therapy, specifically using the Day-Light Classic, on the binding of serotonin transporter in the brain. The study aimed to determine whether light therapy could reduce the binding of serotonin transporter in areas such as the anterior cingulate and prefrontal cortices, which are associated with regulating mood. The study's findings indicate that the Day-Light Classic may significantly address seasonal mood disorders by influencing brain chemistry.

2016

Study Shows Day-Light Classic Effective in Alleviating Symptoms of Nonseasonal Major Depressive Disorder

In a clinical study, university researchers examined the impact of the Day-Light Classic Plus on individuals with Nonseasonal Major Depressive Disorder. Over eight weeks, 122 patients were involved in the study, which compared the effects of light therapy to the use of antidepressants (fluoxetine) and a placebo.

The study concluded that "Bright light treatment, both as monotherapy and in combination with fluoxetine, was efficacious and well tolerated in the treatment of adults with nonseasonal MDD. The combination treatment had the most consistent effects."

2016

The New York Times Rates the Day-Light Classic Plus as the #1 Therapy Lamp

The Day-Light Classic Plus is recognized as the top therapy lamp by the New York Times after undergoing rigorous standards, testing, and expert interviews. Of the 50 lamps evaluated, the Classic Plus stood out for its exceptional performance. The New York Times has consistently rated it as their top pick for the past eight years, highlighting its ability to meet all the specifications recommended by their experts, its reasonable price, and its generous warranty.

2017

Day-Light Swaps Fluorescent Bulbs for Safer, More Efficient LEDs

As Day-Light continues to embrace the latest in lighting technology, it decides to replace the fluorescent bulbs in all its models with energy-efficient LEDs. This upgrade comes with a host of benefits, including increased energy efficiency, a longer lifespan, greater durability, environmental friendliness, and enhanced safety.

2017

The Day-Light Classic is Used in a Clinical Study on Bright Light Therapy for Bipolar Depression

A clinical study explored the efficacy of adjunctive bright light therapy for bipolar depression, using the Day-Light Classic as the light therapy device. The study found that patients who received midday bright light therapy experienced significantly higher remission rates and lower depression scores compared to those receiving a placebo. These findings suggest that the Day-Light Classic may be a valuable tool in managing bipolar depression.

2017

The TheraLite Brand is Launched

After recognizing a need for price-conscious light therapy, the Compass team launched the TheraLite brand: wellness-grade light therapy lamps designed with size and price in mind. They launched with a portable light therapy lamp and expanded to include the TheraLite Aura, a mid-tier lamp with the clinical-grade feature of a long neck combined with the size of a wellness lamp.

2020

COVID-19 Takes Over the World, Paving the Way for the Next Generation of TheraLite Lamps

In 2020, the COVID-19 pandemic took the world by storm. As a result, people were spending more time indoors, and the need for light therapy exploded. To meet this demand, we launched three new TheraLite lamps: the Aura Qi, Halo, and Radiance.
Each wellness lamp delivered the needed 10,000 LUX and had tech upgrades such as alarm clocks, wireless charging, and USB ports. Our goal with these lamps was to introduce office companions as working from home became more mainstream.

2022

Day-Light Used in Studies on Light Therapy for PTSD

A study found that bright light therapy using the Day-Light Classic can effectively reduce PTSD symptoms in combat veterans. While the treatment did not significantly improve depression, anxiety, or sleep disturbance, it shows promise as a potential adjunct therapy for PTSD.